A de Novo Design Probe of a Dopamine Receptor Ligand Based on a Theoretical Approach

By Baginski M.   Claudi F.   Giorgioni G.   Fontenla J.A.   Rosa E.   Cardellini M.  

Bioorganic Chemistry, Vol. 24, Iss. 4, 1996-12 ,pp. : 358-375

Academic Press

Access to resources Recommend Favorite

De novo design of quinazoline derivatives as CDK2 inhibitors: 3D-QSAR, molecular fragment replacement and Volsurf predictions

By Wang Jian   Chen Ya-Dong   Liu Hai-Chun   Lin Guo-Wu   Yang Tao-Tao   Yuan Hao-Liang   Ran Ting   Lu Shuai   Zhang Wei-Wei   Leng Ying   Lu Tao  

Molecular Simulation, Vol. 37, Iss. 10, 2011-09 ,pp. : 824-836

Taylor & Francis Ltd

Access to resources Recommend Favorite

De novo design of PLK1 inhibitors based on 2-amino aromatic heterocyclic scaffold: 3D-QSAR and molecular fragment replacement

By Sun Shanliang   Zhang Liang   Lu Shuai   Liu Haichun   Yuan Haoliang   Chen Yadong   Lu Tao  

Molecular Simulation, Vol. 39, Iss. 12, 2013-10 ,pp. : 975-987

Taylor & Francis Ltd

Access to resources Recommend Favorite

Pharmacological distribution diagrams: A tool for de novo drug design

By Galvez J.   Garcia-Domenech R.   de Gregorio Alapont C.   de Julian-Ortiz J.V.   Popa L.  

Journal of Molecular Graphics, Vol. 14, Iss. 5, 1996-10 ,pp. : 272-276

Elsevier

Access to resources Recommend Favorite

De novo design of a synthetic riboswitch that regulates transcription termination

By Wachsmuth Manja  

Nucleic Acids Research, Vol. 41, Iss. 4, 2013-02 ,pp. : 2541-2551

Oxford University Press

Access to resources Recommend Favorite